Search Result "gastroesophageal carcinoma"
Targeted Therapies in Combination with Radiotherapy in Oesophageal and Gastroesophageal Carcinoma
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 8 Year: 2014 Page: 990-1004
Author(s): F. Cellini, V. Valentini
Immunotherapy for Gastroesophageal Tumors: Is there still Hope forEfficacy?
Journal: Current Cancer Drug Targets
Volume: 22 Issue: 8 Year: 2022 Page: 651-666
Author(s): Hannah Christina Puhr
Current Innovations in Management of Esophageal Carcinoma
Ebook: Frontiers in Drug Design and Discovery
Volume: 8 Year: 2017
Author(s): Julie H. Rowe,Fathima Kamil,Melissa Yan,Curtis J. Wray,Atilla Ertan
Doi: 10.2174/9781681083551117080004
Immunotherapy for the Treatment of Hepatocellular Carcinoma
Ebook: Frontiers in Anti-Cancer Drug Discovery
Volume: 12 Year: 2021
Author(s): Georgios Tsoulfas,Ioannis A. Ziogas,Stepan M. Esagian
Doi: 10.2174/9789811487385121120006
Targetting Esophageal and Gastric Cancers with Monoclonal Antibodies
Journal: Current Topics in Medicinal Chemistry
Volume: 12 Issue: 15 Year: 2012 Page: 1678-1682
Author(s): Emmanuelle Norguet,Laetitia Dahan,Jean-Francois Seitz
Immunotherapy in Gastric Carcinoma: Current Status and Future Perspectives
Journal: Clinical Cancer Drugs
Volume: 2 Issue: 2 Year: 2015 Page: 91-99
Author(s): Lionel Kankeu Fonkoua, Nelson S Yee
A Novel Multiple Tyrosine-kinase Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Solid Tumors: Cabozantinib
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15 Issue: 1 Year: 2015 Page: 37-47
Author(s): Subhajit Roy,Bawneet K. Narang,Shiva K. Rastogi,Ravindra K. Rawal
Targeted Therapy in Advanced Gastric Carcinoma: The Future is Beginning
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 8 Year: 2014 Page: 1026-1038
Author(s): G. Schinzari, A. Cassano, A. Orlandi, M. Basso, C. Barone
Molecular Dynamics in Esophageal Adenocarcinoma: Whoâs in Control?
Journal: Current Cancer Drug Targets
Volume: 20 Issue: 10 Year: 2020 Page: 789-801
Author(s): Tong Dang,Jianyuan Chai
MiR‐372-3p Predicts Response of TACE Patients Treated with Doxorubicin and Enhances Chemosensitivity in Hepatocellular Carcinoma
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 20 Issue: 0 Year: 2020 Page: 1-11
Author(s): Marwa H. Soliman,Mohamed A. Ragheb,Emad M. Elzayat,Mervat S. Mohamed,Nada El-Ekiaby,Ahmed I. Abdelaziz,Abdelhady A. Abdelwahab